ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1257

A Scoping Review of Contextual Factors of Patient Decision Aids in Osteoarthritis

Alexa Meara1, Karine Toupin-April2, Bev Shea3, Liana Fraenkel4, Jennifer Barton5, Peter Brooks6, Maarten de Wit7 and Peter Tugwell8, 1Internal Medicine/Rheumatology, The Ohio State University Wexner Medical Center, Columbus, OH, 2Children’s Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada, 3University of Ottawa, Ottawa, ON, Canada, 4Yale University, New Haven, CT, 5Oregon Health and Science University, Portland, OR, 6The University of Queensland, Sidney, Australia, 7EULAR standing committee of PARE, Zurich, Switzerland, 8Center For Global Health, Institute of Population Hlth, Ottawa, ON, Canada

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Decision analysis, osteoarthritis and patient assistance

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Patient Outcomes, Preferences, and Attitudes Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Patient decision aids (PDAs) have been developed to help patients make informed health care decisions that are consistent with their values and preferences. Patients diagnosed with osteoarthritis (OA) can choose from a wide array of treatments, such as physical therapy, exercise, medication, joint injections, and surgery (when indicated). OMERACT Filter 2.0 highlights the importance of measuring relevant contextual factors (i.e., any factors that indirectly influence the process or outcomes of interventions) in clinical studies evaluating PDAs. However, very few studies have assessed these factors. A Cochrane Systemic Review published in 2017 performed an in-depth review of benefits of PDAs and performed subgroup analyses based on the timing of the use of PDAs (i.e., before or during a consultation) but did not find any impact. The current study sought to systematically search the literature in order to appraise and summarize contextual factors that were assessed in randomized controlled trials (RCTs) of PDAs in OA.

Methods: We conducted a scoping literature review using Medline, Embase, AMED, PsycInfo and Cochrane Central from inception of the databases to June 14 2017. The search strategy was based on the Cochrane systematic review of PDAs and MeSh terms related to OA. Citations were included if they reported on RCTs evaluating PDAs compared to any control group in patients with OA.

Results: 235 citations were identified after removal of duplicates and six RCTs of PDA in OA were included. Of the six included trials, four were about the effectiveness of PDAs for knee arthroplasty and two others were for overall management of OA. Three RCTs measured PDA format as the main predictor of decision making outcomes (i.e., internet vs. DVD PDAs, and paper-based educational booklet vs. video-booklet PDA). One of these RCTs also examined the impact of patient testimonials. A fourth trial measured the setting in which the PDA was used (i.e., community or academic hospital setting) and another trial conducted subgroup analyses for patients’ characteristics. Format and content of the PDA and patients’ younger age (i.e., 50-55 years old), sex (female) and willingness to undergo surgery at baseline were linked to better decision-making outcomes.

Conclusion:

Contextual factors assessed in RCTS of PDAs in OA include format, content and setting of the PDA and patients’ characteristics. There is a need for more research to assess contextual factors in PDA RCTs in rheumatology to fulfill the OMERACT filter 2.0. Potential contextual factors to consider include the timing in which PDAs are used and the interface between the PDA and patients (e.g., tailoring to patients’ health literacy, understanding, etc). Future work will be also be needed to assess contextual factors of PDAs in other prevalent rheumatic conditions.


Disclosure: A. Meara, None; K. Toupin-April, None; B. Shea, None; L. Fraenkel, None; J. Barton, None; P. Brooks, None; M. de Wit, None; P. Tugwell, None.

To cite this abstract in AMA style:

Meara A, Toupin-April K, Shea B, Fraenkel L, Barton J, Brooks P, de Wit M, Tugwell P. A Scoping Review of Contextual Factors of Patient Decision Aids in Osteoarthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/a-scoping-review-of-contextual-factors-of-patient-decision-aids-in-osteoarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-scoping-review-of-contextual-factors-of-patient-decision-aids-in-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology